4D Molecular Therapeutics News

H.C. Wainwright Maintains 4D Molecular Therapeutics(FDMT.US) With Buy Rating, Maintains Target Price $36

Futu NewsJan 22 23:31

Leerink Partners Maintains 4D Molecular Therapeutics(FDMT.US) With Buy Rating, Cuts Target Price to $27

Futu NewsJan 14 02:31

4D Molecular Therapeutics Is Maintained at Outperform by Leerink Partners

Dow JonesJan 14 00:23

Morgan Stanley Maintains Underweight on 4D Molecular Therapeutics, Lowers Price Target to $6

BenzingaJan 14 00:16

H.C. Wainwright Maintains 4D Molecular Therapeutics(FDMT.US) With Buy Rating, Maintains Target Price $36

Futu NewsJan 13 20:34

4D Molecular Therapeutics Analyst Ratings

BenzingaJan 13 20:02

HC Wainwright & Co. Reiterates Buy on 4D Molecular Therapeutics, Maintains $36 Price Target

BenzingaJan 13 20:01

Barclays Sticks to Their Buy Rating for 4D Molecular Therapeutics (FDMT)

TipRanksJan 12 21:28

BofA Securities Maintains 4D Molecular Therapeutics(FDMT.US) With Buy Rating, Cuts Target Price to $42

Futu NewsJan 12 00:31

BMO Capital Downgrades 4D Molecular Therapeutics(FDMT.US) to Hold Rating, Cuts Target Price to $15

Futu NewsJan 11 07:32

BofA Securities Maintains 4D Molecular Therapeutics(FDMT.US) With Buy Rating, Cuts Target Price to $46

Futu NewsDec 18, 2024 20:31

4D Molecular Therapeutics Analyst Ratings

BenzingaNov 21, 2024 19:24

Morgan Stanley Initiates 4D Molecular Therapeutics(FDMT.US) With Sell Rating, Announces Target Price $8

Futu NewsNov 21, 2024 18:31

Chardan Capital Maintains 4D Molecular Therapeutics(FDMT.US) With Buy Rating, Maintains Target Price $39

Futu NewsNov 15, 2024 06:32

4D Molecular Therapeutics Is Maintained at Buy by Chardan Capital

Dow JonesNov 15, 2024 05:55

RBC Capital Maintains 4D Molecular Therapeutics(FDMT.US) With Buy Rating

Futu NewsNov 14, 2024 20:34

H.C. Wainwright Maintains 4D Molecular Therapeutics(FDMT.US) With Buy Rating, Maintains Target Price $36

Futu NewsNov 14, 2024 19:31

Barclays Maintains 4D Molecular Therapeutics(FDMT.US) With Buy Rating, Maintains Target Price $45

Futu NewsNov 14, 2024 18:34

Barclays Reaffirms Their Buy Rating on 4D Molecular Therapeutics (FDMT)

TipRanksNov 14, 2024 17:54

4D Molecular Therapeutics Downgraded at Cantor Following Wet AMD Asset Data

Seeking AlphaSep 24, 2024 01:42